neuroloop GmbH

Neuroloop operates in medical devices and bioelectronic therapeutics, with a focused application in resistant hypertension. Its product concept combines an implantable device with selective vagal-nerve stimulation and a closed-loop approach to blood-pressure regulation. That places its work at the intersection of neuromodulation, implant engineering, and treatment of hypertension rather than in general-purpose digital health. The company’s described advantage is its specific therapeutic focus and the integration of engineering, software, clinical research, production, and regulatory work; its website also describes close research ties and support from parent company B. Braun. The available company information does not identify named competitors, so direct competitor comparisons or relative market-share claims cannot be substantiated. The listed similarity results refer to Neuroloop itself and are not independent peer companies. Its market position is therefore best understood as that of a specialized MedTech developer pursuing an implant-based bioelectronic treatment approach for patients whose blood pressure remains uncontrolled with medication.

Founded in 2015, Neuroloop has developed a focused medical-device program around vagal-nerve stimulation for blood-pressure regulation. The dated patent-related timeline provides several technical milestones: an electronic implant entry in 2022, implant and electrode-related entries in 2023, and multiple implant and wrap-cuff publications dated Sep 25, 2024. Together, these records indicate sustained work on implant form factors and electrode arrangements, although they do not establish that a product has launched or received regulatory approval. The company is described as having an employee-size band of 11–50, while one current leadership position is identified: co-founder and CTO Dennis Plachta. Neuroloop’s stated support from B. The clearest inflection points in the available history are its founding, the sequence of implant-related patent milestones, and its ongoing recruitment across several disciplines.